Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MabThera in RA after inadequate anti-TNF response
NCT00576433Phase 4Completed
- Sponsor
- Roche
- Start
- Dec 2007
- Primary completion
- Nov 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of rituximab in rheumatoid arthritis (RA), sponsored by Roche. Started Dec 2007; status: completed.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00576433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00576433.